site stats

Cynapsedx

http://email.cynapsedx.com/partnering WebJul 12, 2012 · CynapseDx's latest funding round was a Seed VC for $0.11M on July 12, 2012. View all funding This profile has not been claimed. You're more than your latest …

News - Neurodegenerative Disease CynapseDx

WebCynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from neurodegenerative diseases. View company Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via … http://mta.cynapsedx.com/partnering high risk investments 2019 https://lse-entrepreneurs.org

CynapseDx Company Profile Management and Employees List

WebCynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people … WebCynapseDx Company Name CynapseDx Main Industry Business Services, Research & Development Website www.cynapsedx.com Contact Information Headquarters 131 Mount Pleasant, Liverpool, England, L3 5TF, United Kingdom … http://cynapsedx.com/technology/ high risk investments 2020

CynapseDx - Crunchbase Company Profile & Funding

Category:CynapseDx CEO, Founder, Key Executive Team, Board of Directors …

Tags:Cynapsedx

Cynapsedx

Novel Aggregated Biomarker Assay Technology

WebGemelli Biotech's main competitors include Vivid Genomics, ALCEDIAG, Quadrant Biosciences and CynapseDx. Compare Gemelli Biotech to its competitors by revenue, employee growth and other metrics at Craft. Advanced Product Craft Intelligence Portal Craft API Supplier Intelligence Platform Company Search (Free) Solutions Craft for … WebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is an antibody coated large ultra-dense …

Cynapsedx

Did you know?

Webcynapsedx.com Claim your profile to get in front of buyers, investors, and analysts. Submit Your Analyst Briefing Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more. Overview & Products Financials People Alternatives & Competitors Customers CynapseDx has not claimed their Profile. WebSummary Overview Number of Founded Organizations 1 CB Rank (Person) 672,540 Gender Male Christopher Stanley is the co-founder of CynapseDx. Jobs Number of Current Jobs 1 Christopher Stanley is the Co-Founder & CTO at CynapseDx. CynapseDx Co-Founder & CTO Recent News and Activity There is no recent news or activity for this profile.

WebJun 8, 2024 · CynapseDx develops products to isolate proteins or cells from whole blood. Its primary focus is neurodegenerative diseases, such as Parkinson’s or Alzheimer’s Disease.

WebCynapseDx develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from a neurodegenerative disease, such as Alzheimer's or Parkinson's Diseases. WebCynapseDx is currently conducting a trial to demonstrate that our assays can save money and resources for any health service by cost effectively identifying patients mis …

WebCynapseDx is currently conducting a trial to demonstrate that our assays can save money and resources for any health service by cost effectively identifying patients mis-diagnosed with Parkinson’s disease. This will secure the funding to complete the development of all 3 assays for ß-amyloid, α-synuclein and phospho-tau. ...

http://forum.cynapsedx.com/ how many calories oikos triple zero yogurtWebwww.cynapsedx.com/about-us Formerly Known As Cell Cap Technologies Ownership Status Acquired/Merged (Operating Subsidiary) Financing Status Formerly VC-backed … how many calories of glycogen are storedWebCynapseDx has incorporated three technical enhancements to allow us to measure the oligomeric and aggregated forms of these biomarker proteins in blood. Immunoconcentration. We use antibody-coated magnetic … how many calories of protein per gramsWebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is an antibody coated large ultra-dense magnetic particle that can force its way through the viscous, cell-rich media of blood to encou nter and bind proteins. These can be free in plasma, or cell-associated. how many calories of energy per gram in carbsWebExplore {CynapseDx's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. CynapseDx CEO, Founder, Key Executive Team, Board of Directors & Employees high risk investments when youngWebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is an antibody coated large ultra-dense … how many calories of riceWebCynapseDx develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from a neurodegenerative disease, such as … high risk investments in south africa